Scientific Innovation

Pipeline

Pfizer is advancing disruptive science and accelerating breakthrough therapies with the goal of delivering transformative medicines and vaccines and the development of potential cures to patients in need.

Our pipeline is focused on areas where we believe we can make a significant contribution to patients. As of January 31, 2017, Pfizer’s pipeline from Phase 1 to registration is comprised of 96 investigational therapies. Learn more about how our pipeline is driving our Global Business and find out how Pfizer is collaborating with peers, industry and third parties to fill our pipeline with potential therapies that meet the needs of patients today.